| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.41e-07 | 4 | 89 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.08e-06 | 18 | 89 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.70e-06 | 6 | 89 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.77e-06 | 129 | 89 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.05e-06 | 151 | 89 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.06e-05 | 31 | 89 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.37e-05 | 33 | 89 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 4.78e-05 | 45 | 89 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | L27 domain binding | 1.17e-04 | 4 | 89 | 2 | GO:0097016 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.42e-04 | 23 | 89 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 3.87e-04 | 32 | 89 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | spectrin binding | 4.63e-04 | 34 | 89 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM6 STIM1 APOL3 SLC39A4 ORAI2 SLC4A3 RYR1 RYR2 RYR3 SLC4A1 ITPR1 | 5.41e-04 | 758 | 89 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM6 STIM1 APOL3 SLC39A4 ORAI2 SLC4A3 RYR1 RYR2 RYR3 SLC4A1 ITPR1 | 7.85e-04 | 793 | 89 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.57e-04 | 343 | 89 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.02e-03 | 459 | 89 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.11e-03 | 465 | 89 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.26e-03 | 12 | 89 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.48e-03 | 13 | 89 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.48e-03 | 13 | 89 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.73e-03 | 14 | 89 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 1.99e-03 | 15 | 89 | 2 | GO:0052650 | |
| GeneOntologyMolecularFunction | channel activity | 2.37e-03 | 525 | 89 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.40e-03 | 526 | 89 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | STIM1 ROCK2 SPTBN4 CCDC88C LIN7C SYNE1 SPTAN1 SPTB NFKB1 MAST1 EPB41L2 SLC4A1 | 3.43e-03 | 1099 | 89 | 12 | GO:0008092 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.57e-03 | 140 | 89 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.68e-03 | 230 | 89 | 5 | GO:0005516 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 6.85e-07 | 39 | 89 | 5 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.25e-05 | 11 | 89 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.92e-05 | 37 | 89 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 2.73e-05 | 14 | 89 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 3.85e-05 | 44 | 89 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.07e-05 | 146 | 89 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.23e-05 | 147 | 89 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 4.56e-05 | 149 | 89 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 4.91e-05 | 392 | 89 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.28e-05 | 153 | 89 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | AKAP6 STIM1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 6.34e-05 | 611 | 89 | 11 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | AKAP6 STIM1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 7.44e-05 | 622 | 89 | 11 | GO:0006873 |
| GeneOntologyBiologicalProcess | response to caffeine | 9.76e-05 | 21 | 89 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 1.15e-04 | 438 | 89 | 9 | GO:0032970 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.30e-04 | 113 | 89 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.30e-04 | 259 | 89 | 7 | GO:0051651 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | AKAP6 STIM1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 2.23e-04 | 705 | 89 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | AKAP6 STIM1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 2.57e-04 | 717 | 89 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | maintenance of location | 3.13e-04 | 396 | 89 | 8 | GO:0051235 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 3.20e-04 | 300 | 89 | 7 | GO:0110053 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 3.45e-04 | 77 | 89 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | metal ion transport | AKAP6 TRPM6 STIM1 SPTBN4 SLC39A4 TSC1 ORAI2 RYR1 RYR2 ARF1 RYR3 ITPR1 CEMIP | 3.47e-04 | 1000 | 89 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.49e-04 | 509 | 89 | 9 | GO:0006816 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.56e-04 | 217 | 89 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 3.80e-04 | 79 | 89 | 4 | GO:0050853 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | AKAP6 TRPM6 STIM1 SLC39A4 ORAI2 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 4.08e-04 | 1017 | 89 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 4.78e-04 | 422 | 89 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | protein localization to basolateral plasma membrane | 5.07e-04 | 8 | 89 | 2 | GO:1903361 | |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 ROCK2 SPTBN4 CCDC88C PPFIA1 SPTAN1 SPTB TSC1 THSD7B EPB41L2 RYR2 ARF1 | 5.37e-04 | 912 | 89 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 5.45e-04 | 154 | 89 | 5 | GO:0051928 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 5.87e-04 | 38 | 89 | 3 | GO:0015701 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 5.98e-04 | 89 | 89 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 6.10e-04 | 438 | 89 | 8 | GO:1902903 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 6.34e-04 | 39 | 89 | 3 | GO:1901021 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 6.50e-04 | 91 | 89 | 4 | GO:0060998 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 6.84e-04 | 40 | 89 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | synapse organization | ROCK2 SPTBN4 PPFIA4 PPFIA2 PPFIA1 ITSN1 SPTB LRRTM4 TSC1 ARF1 | 7.32e-04 | 685 | 89 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | AKAP6 TRPM6 STIM1 SPTBN4 SLC39A4 TSC1 ORAI2 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 7.48e-04 | 1374 | 89 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 7.65e-04 | 166 | 89 | 5 | GO:0014074 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid receptor signaling pathway | 8.10e-04 | 10 | 89 | 2 | GO:0048387 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 9.26e-04 | 359 | 89 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 9.26e-04 | 100 | 89 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 9.45e-04 | 174 | 89 | 5 | GO:1904064 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | AKAP6 TRPM6 STIM1 SLC39A4 ORAI2 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 ITPR1 CEMIP | 9.62e-04 | 1115 | 89 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | maintenance of epithelial cell apical/basal polarity | 9.87e-04 | 11 | 89 | 2 | GO:0045199 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 1.00e-03 | 364 | 89 | 7 | GO:0036293 | |
| GeneOntologyBiologicalProcess | actin filament capping | 1.03e-03 | 46 | 89 | 3 | GO:0051693 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.03e-03 | 266 | 89 | 6 | GO:0043270 | |
| GeneOntologyCellularComponent | spectrin | 3.64e-08 | 9 | 88 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.26e-06 | 45 | 88 | 5 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.92e-06 | 88 | 88 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.47e-06 | 10 | 88 | 3 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasm | 8.68e-06 | 114 | 88 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | cell cortex | 2.64e-05 | 371 | 88 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 4.18e-05 | 46 | 88 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 SPTBN4 DOCK5 CCDC88C LIN7C PPFIA1 SPTAN1 EIF4G2 PRKCH PCDH12 EPB41L2 ARF1 SLC4A1 LIN7A | 5.45e-05 | 976 | 88 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | postsynapse | ROCK2 LIN7C SYNE1 PPFIA2 PPFIA1 SPTAN1 ITSN1 SPTB LRRTM4 EIF4G2 TSC1 ARF1 LIN7A ITPR1 | 8.56e-05 | 1018 | 88 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | sarcomere | 8.74e-05 | 249 | 88 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.55e-04 | 273 | 88 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | MPP7-DLG1-LIN7 complex | 1.74e-04 | 5 | 88 | 2 | GO:0097025 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 SPTBN4 CCDC88C LIN7C SPTAN1 EIF4G2 PRKCH PCDH12 SLC4A1 LIN7A | 1.88e-04 | 591 | 88 | 10 | GO:0005911 |
| GeneOntologyCellularComponent | intercalated disc | 1.94e-04 | 68 | 88 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.15e-04 | 129 | 88 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.24e-04 | 290 | 88 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.56e-04 | 73 | 88 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.67e-04 | 503 | 88 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | Z disc | 4.45e-04 | 151 | 88 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | junctional membrane complex | 6.19e-04 | 9 | 88 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.28e-04 | 451 | 88 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 6.43e-04 | 93 | 88 | 4 | GO:0030864 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 6.70e-04 | 94 | 88 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | I band | 6.85e-04 | 166 | 88 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | asymmetric synapse | 9.03e-04 | 477 | 88 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.11e-03 | 185 | 88 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.62e-03 | 523 | 88 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | specific granule lumen | 2.28e-03 | 62 | 88 | 3 | GO:0035580 | |
| GeneOntologyCellularComponent | paranode region of axon | 2.29e-03 | 17 | 88 | 2 | GO:0033270 | |
| GeneOntologyCellularComponent | nuclear envelope | 2.48e-03 | 560 | 88 | 8 | GO:0005635 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.88e-03 | 230 | 88 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.98e-03 | 141 | 88 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | axon | STIM1 SPTBN4 PPFIA2 PPFIA1 SPTAN1 ITSN1 EIF4G2 MAST1 TSC1 ORAI2 | 4.20e-03 | 891 | 88 | 10 | GO:0030424 |
| Domain | RIH_assoc | 8.21e-09 | 6 | 92 | 4 | PF08454 | |
| Domain | RIH_assoc-dom | 8.21e-09 | 6 | 92 | 4 | IPR013662 | |
| Domain | RIH_dom | 8.21e-09 | 6 | 92 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.21e-09 | 6 | 92 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.21e-09 | 6 | 92 | 4 | IPR015925 | |
| Domain | - | 8.21e-09 | 6 | 92 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.21e-09 | 6 | 92 | 4 | PF01365 | |
| Domain | Ins145_P3_rec | 8.21e-09 | 6 | 92 | 4 | PF08709 | |
| Domain | MIR | 1.13e-07 | 10 | 92 | 4 | PS50919 | |
| Domain | MIR | 1.13e-07 | 10 | 92 | 4 | PF02815 | |
| Domain | MIR | 1.13e-07 | 10 | 92 | 4 | SM00472 | |
| Domain | MIR_motif | 1.13e-07 | 10 | 92 | 4 | IPR016093 | |
| Domain | Ryanrecept_TM4-6 | 1.16e-07 | 3 | 92 | 3 | IPR009460 | |
| Domain | RyR | 1.16e-07 | 3 | 92 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.16e-07 | 3 | 92 | 3 | IPR003032 | |
| Domain | RR_TM4-6 | 1.16e-07 | 3 | 92 | 3 | PF06459 | |
| Domain | Ryan_recept | 1.16e-07 | 3 | 92 | 3 | IPR013333 | |
| Domain | Spectrin/alpha-actinin | 4.71e-07 | 32 | 92 | 5 | IPR018159 | |
| Domain | SPEC | 4.71e-07 | 32 | 92 | 5 | SM00150 | |
| Domain | SAM_2 | 2.16e-06 | 43 | 92 | 5 | PF07647 | |
| Domain | Liprin | 2.29e-06 | 6 | 92 | 3 | IPR029515 | |
| Domain | Spectrin | 4.54e-06 | 23 | 92 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 1.19e-05 | 29 | 92 | 4 | IPR002017 | |
| Domain | Anion_exchange_CS | 7.18e-05 | 3 | 92 | 2 | IPR018241 | |
| Domain | SAM | 7.38e-05 | 88 | 92 | 5 | SM00454 | |
| Domain | Ank_2 | 9.30e-05 | 215 | 92 | 7 | PF12796 | |
| Domain | SAM_DOMAIN | 1.06e-04 | 95 | 92 | 5 | PS50105 | |
| Domain | SAM | 1.17e-04 | 97 | 92 | 5 | IPR001660 | |
| Domain | Ank | 1.34e-04 | 228 | 92 | 7 | PF00023 | |
| Domain | Spectrin_bsu | 1.43e-04 | 4 | 92 | 2 | IPR016343 | |
| Domain | - | 1.78e-04 | 106 | 92 | 5 | 1.10.150.50 | |
| Domain | Actinin_actin-bd_CS | 1.91e-04 | 23 | 92 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 1.91e-04 | 23 | 92 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.91e-04 | 23 | 92 | 3 | PS00019 | |
| Domain | - | 2.24e-04 | 248 | 92 | 7 | 1.25.40.20 | |
| Domain | Anion_exchange | 2.38e-04 | 5 | 92 | 2 | IPR001717 | |
| Domain | ANK | 2.42e-04 | 251 | 92 | 7 | SM00248 | |
| Domain | Ion_trans_dom | 2.50e-04 | 114 | 92 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.50e-04 | 114 | 92 | 5 | PF00520 | |
| Domain | ANK_REPEAT | 2.54e-04 | 253 | 92 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.60e-04 | 254 | 92 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.60e-04 | 254 | 92 | 7 | PS50297 | |
| Domain | SAM/pointed | 2.82e-04 | 117 | 92 | 5 | IPR013761 | |
| Domain | Ankyrin_rpt | 3.13e-04 | 262 | 92 | 7 | IPR002110 | |
| Domain | ANION_EXCHANGER_2 | 4.96e-04 | 7 | 92 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 4.96e-04 | 7 | 92 | 2 | PS00219 | |
| Domain | Band3_cytoplasmic_dom | 8.45e-04 | 9 | 92 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 8.45e-04 | 9 | 92 | 2 | PF07565 | |
| Domain | - | 8.45e-04 | 9 | 92 | 2 | 3.40.1100.10 | |
| Domain | EF_hand_dom | 1.01e-03 | 232 | 92 | 6 | IPR002048 | |
| Domain | L27_C | 1.05e-03 | 10 | 92 | 2 | IPR014775 | |
| Domain | HCO3_cotransp | 1.05e-03 | 10 | 92 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.05e-03 | 10 | 92 | 2 | IPR011531 | |
| Domain | L27 | 1.05e-03 | 10 | 92 | 2 | PF02828 | |
| Domain | PTrfase/Anion_transptr | 1.05e-03 | 10 | 92 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.05e-03 | 10 | 92 | 2 | IPR003020 | |
| Domain | Pkinase_C | 1.16e-03 | 42 | 92 | 3 | PF00433 | |
| Domain | ARM-type_fold | 1.43e-03 | 339 | 92 | 7 | IPR016024 | |
| Domain | L27 | 1.81e-03 | 13 | 92 | 2 | SM00569 | |
| Domain | L27 | 1.81e-03 | 13 | 92 | 2 | PS51022 | |
| Domain | L27_dom | 1.81e-03 | 13 | 92 | 2 | IPR004172 | |
| Domain | - | 1.84e-03 | 261 | 92 | 6 | 1.10.238.10 | |
| Domain | AGC-kinase_C | 2.65e-03 | 56 | 92 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.65e-03 | 56 | 92 | 3 | PS51285 | |
| Domain | S_TK_X | 2.65e-03 | 56 | 92 | 3 | SM00133 | |
| Domain | EF-hand-dom_pair | 2.95e-03 | 287 | 92 | 6 | IPR011992 | |
| Domain | CH | 4.05e-03 | 65 | 92 | 3 | SM00033 | |
| Domain | SAM_1 | 4.60e-03 | 68 | 92 | 3 | PF00536 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.46e-08 | 23 | 72 | 5 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.46e-08 | 23 | 72 | 5 | M12627 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.84e-07 | 87 | 72 | 7 | M27617 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.06e-07 | 54 | 72 | 6 | M27460 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.32e-07 | 13 | 72 | 4 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.29e-06 | 19 | 72 | 4 | M47760 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 5.91e-06 | 51 | 72 | 5 | MM14499 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 5.91e-06 | 51 | 72 | 5 | M4281 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.86e-06 | 54 | 72 | 5 | MM15202 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.49e-05 | 10 | 72 | 3 | MM15112 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.05e-05 | 11 | 72 | 3 | M47958 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 2.14e-05 | 166 | 72 | 7 | M608 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.28e-05 | 67 | 72 | 5 | MM15327 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.05e-05 | 38 | 72 | 4 | MM14969 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.20e-05 | 130 | 72 | 6 | M27454 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 5.43e-05 | 131 | 72 | 6 | MM15717 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.82e-05 | 16 | 72 | 3 | M26945 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.25e-05 | 17 | 72 | 3 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.25e-05 | 17 | 72 | 3 | MM14907 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 8.51e-05 | 88 | 72 | 5 | M42580 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 9.87e-05 | 18 | 72 | 3 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.87e-05 | 18 | 72 | 3 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 9.87e-05 | 18 | 72 | 3 | M27043 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.87e-05 | 18 | 72 | 3 | M13015 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.33e-04 | 154 | 72 | 6 | MM15974 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.37e-04 | 20 | 72 | 3 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.37e-04 | 20 | 72 | 3 | MM14991 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.43e-04 | 156 | 72 | 6 | M39475 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.71e-04 | 102 | 72 | 5 | M27648 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.79e-04 | 103 | 72 | 5 | MM15196 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.83e-04 | 22 | 72 | 3 | M27445 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.88e-04 | 56 | 72 | 4 | M27616 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.39e-04 | 24 | 72 | 3 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.39e-04 | 24 | 72 | 3 | M630 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.44e-04 | 110 | 72 | 5 | MM15350 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL | 2.55e-04 | 5 | 72 | 2 | M49017 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.97e-04 | 63 | 72 | 4 | M11187 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.82e-04 | 28 | 72 | 3 | MM15188 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.82e-04 | 28 | 72 | 3 | M924 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.18e-04 | 31 | 72 | 3 | M877 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 5.50e-04 | 74 | 72 | 4 | M48080 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.87e-04 | 203 | 72 | 6 | M5485 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 6.24e-04 | 33 | 72 | 3 | M39745 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPM6 CUL1 ANGPTL4 PSMD1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 | 6.32e-04 | 681 | 72 | 11 | MM14985 |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | STIM1 CUL1 PAG1 ASB6 NFKB1 PSMD1 UBE3C KIR2DL3 ORAI2 ARF1 ITPR1 SOS1 | 9.17e-04 | 828 | 72 | 12 | M1058 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.19e-04 | 147 | 72 | 5 | MM15854 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 9.69e-04 | 86 | 72 | 4 | M601 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | STIM1 CUL1 PAG1 ASB6 NFKB1 PSMD1 UBE3C KIR2DL3 ARF1 ITPR1 SOS1 | 9.89e-04 | 719 | 72 | 11 | MM14540 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.04e-03 | 151 | 72 | 5 | M39329 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.13e-03 | 10 | 72 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.13e-03 | 10 | 72 | 2 | MM15073 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPM6 CUL1 ANGPTL4 PSMD1 SLC39A4 SLC4A3 RYR1 RYR2 ARF1 RYR3 SLC4A1 | 1.20e-03 | 736 | 72 | 11 | M27287 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.20e-03 | 156 | 72 | 5 | M27097 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.36e-03 | 43 | 72 | 3 | M27443 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.54e-03 | 165 | 72 | 5 | MM15026 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.58e-03 | 335 | 72 | 7 | MM14503 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.63e-03 | 99 | 72 | 4 | MM14910 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 1.66e-03 | 46 | 72 | 3 | M48105 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.66e-03 | 168 | 72 | 5 | MM14785 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 1.70e-03 | 100 | 72 | 4 | M27467 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.79e-11 | 4 | 93 | 4 | 23413940 | |
| Pubmed | 4.79e-11 | 4 | 93 | 4 | 9607712 | ||
| Pubmed | 7.16e-10 | 6 | 93 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 7.16e-10 | 6 | 93 | 4 | 25966694 | |
| Pubmed | 7.16e-10 | 6 | 93 | 4 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 7.16e-10 | 6 | 93 | 4 | 16844763 | |
| Pubmed | 1.67e-09 | 7 | 93 | 4 | 11860456 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 3.33e-09 | 8 | 93 | 4 | 30563862 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 3.33e-09 | 8 | 93 | 4 | 12634303 | |
| Pubmed | AKAP6 SPTBN4 NRBP1 NAA25 VPS45 IFT172 SYNE1 SPTAN1 ITSN1 SPTB EIF4G2 LRRCC1 MAST1 PSMD1 TNKS2 SLC4A3 RYR3 SOS1 | 7.72e-09 | 1285 | 93 | 18 | 35914814 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 1.66e-08 | 30 | 93 | 5 | 16186258 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18403125 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7876312 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.85e-08 | 3 | 93 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.85e-08 | 3 | 93 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.85e-08 | 3 | 93 | 3 | 10473538 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.85e-08 | 3 | 93 | 3 | 9204703 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.85e-08 | 3 | 93 | 3 | 12213830 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 9242641 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 25239916 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18643873 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 11159936 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 1.85e-08 | 3 | 93 | 3 | 9986730 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.85e-08 | 3 | 93 | 3 | 4600883 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 7635066 | ||
| Pubmed | 3.36e-08 | 13 | 93 | 4 | 18796539 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 19120137 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 23482488 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 18206662 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 9384575 | ||
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 1.84e-07 | 5 | 93 | 3 | 9124414 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 23918386 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 19013515 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.84e-07 | 5 | 93 | 3 | 19011160 | |
| Pubmed | ROCK2 SPTBN4 PHKB VPS45 PPFIA4 SYNE1 PPFIA2 PPFIA1 SPTAN1 ITSN1 SPTB EIF4G2 LRRCC1 MAST1 TSC1 EPB41L2 SLC4A1 | 2.25e-07 | 1431 | 93 | 17 | 37142655 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.68e-07 | 6 | 93 | 3 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.68e-07 | 6 | 93 | 3 | 14592808 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 19009018 | ||
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 3.68e-07 | 6 | 93 | 3 | 21618221 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 5.80e-07 | 25 | 93 | 4 | 8493579 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 20962236 | ||
| Pubmed | Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. | 6.43e-07 | 7 | 93 | 3 | 11931740 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.03e-06 | 8 | 93 | 3 | 19033399 | |
| Pubmed | Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. | 1.54e-06 | 9 | 93 | 3 | 12629171 | |
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 25737585 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 12923177 | ||
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 18054859 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC88C PHKB VPS45 ITSN1 NFKB1 EIF4G2 NUP88 LRRCC1 TSC1 UBE3C ARF1 ARF3 | 2.96e-06 | 853 | 93 | 12 | 28718761 |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 3.01e-06 | 11 | 93 | 3 | 17607528 | |
| Pubmed | Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. | 3.01e-06 | 11 | 93 | 3 | 19169254 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.30e-06 | 38 | 93 | 4 | 30786075 | |
| Pubmed | 3.39e-06 | 151 | 93 | 6 | 17043677 | ||
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 19095005 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 4.00e-06 | 12 | 93 | 3 | 9624153 | |
| Pubmed | 5.26e-06 | 163 | 93 | 6 | 16512683 | ||
| Pubmed | AKAP6 TRPM6 PHKB TICRR PANK3 PPFIA1 ITSN1 PLCL2 EIF4G2 ZBTB40 PSMD1 LRRC18 ITPR1 | 6.30e-06 | 1084 | 93 | 13 | 11544199 | |
| Pubmed | Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. | 7.07e-06 | 2 | 93 | 2 | 25359276 | |
| Pubmed | Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population. | 7.07e-06 | 2 | 93 | 2 | 26423800 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 2474826 | ||
| Pubmed | Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. | 7.07e-06 | 2 | 93 | 2 | 33846289 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20875478 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9489997 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17259277 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 7.07e-06 | 2 | 93 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.07e-06 | 2 | 93 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.07e-06 | 2 | 93 | 2 | 26009179 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12654335 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24193021 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32899693 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 14592949 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8898078 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15248031 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23686481 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 14679201 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 14550562 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 25051373 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9799464 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15070709 | ||
| Pubmed | KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles. | 7.07e-06 | 2 | 93 | 2 | 27030405 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 7.07e-06 | 2 | 93 | 2 | 15033925 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 7.07e-06 | 2 | 93 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 7.07e-06 | 2 | 93 | 2 | 11500519 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 1577740 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8661066 | ||
| Pubmed | Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. | 7.07e-06 | 2 | 93 | 2 | 15004172 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30185837 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 7.07e-06 | 2 | 93 | 2 | 21531043 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 16678258 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12565913 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9192302 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 7556644 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 7.07e-06 | 2 | 93 | 2 | 15894801 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30542613 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15280431 | ||
| Interaction | PPFIA2 interactions | 1.49e-08 | 37 | 91 | 6 | int:PPFIA2 | |
| Interaction | ANKRD20A4P interactions | 1.76e-06 | 6 | 91 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 3.08e-06 | 7 | 91 | 3 | int:ANKRD20A2P | |
| Interaction | ANK1 interactions | 5.35e-06 | 56 | 91 | 5 | int:ANK1 | |
| Interaction | RYR2 interactions | 6.37e-06 | 58 | 91 | 5 | int:RYR2 | |
| Interaction | ANKRD20A1 interactions | 1.43e-05 | 11 | 91 | 3 | int:ANKRD20A1 | |
| Interaction | AKAP6 interactions | 5.79e-05 | 17 | 91 | 3 | int:AKAP6 | |
| Interaction | PTPRS interactions | 6.80e-05 | 153 | 91 | 6 | int:PTPRS | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.23e-08 | 3 | 64 | 3 | 287 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.47e-06 | 7 | 64 | 3 | 1113 | |
| GeneFamily | Sterile alpha motif domain containing | 1.48e-05 | 88 | 64 | 5 | 760 | |
| GeneFamily | Ankyrin repeat domain containing | 2.29e-05 | 242 | 64 | 7 | 403 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 4.37e-04 | 9 | 64 | 2 | 1223 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.08e-04 | 206 | 64 | 5 | 682 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.82e-03 | 18 | 64 | 2 | 620 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 5.37e-03 | 31 | 64 | 2 | 357 | |
| GeneFamily | EF-hand domain containing | 7.55e-03 | 219 | 64 | 4 | 863 | |
| Coexpression | HOOI_ST7_TARGETS_DN | 3.49e-06 | 115 | 93 | 6 | M14801 | |
| Coexpression | HO_LIVER_CANCER_VASCULAR_INVASION | 1.21e-05 | 13 | 93 | 3 | M8773 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DOCK5 CCDC88C PAG1 LIN7C ANKRD20A4P PLCL2 PIP5K1B SLC39A4 ANKRD20A3P ANKRD20A8P ANKRD20A1 RYR1 CEMIP | 2.44e-05 | 930 | 93 | 13 | MM893 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.85e-05 | 166 | 93 | 6 | M39026 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-06 | 177 | 93 | 6 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-06 | 178 | 93 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 186 | 93 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 194 | 93 | 6 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-06 | 198 | 93 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.84e-06 | 199 | 93 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.84e-06 | 199 | 93 | 6 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.20e-06 | 131 | 93 | 5 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 160 | 93 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 160 | 93 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 168 | 93 | 5 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.97e-05 | 171 | 93 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.14e-05 | 173 | 93 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 174 | 93 | 5 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 3.31e-05 | 175 | 93 | 5 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-05 | 175 | 93 | 5 | 4655d3daa95e8ffa7d5ee4180de06b2fec361bfb | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 3.31e-05 | 175 | 93 | 5 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 178 | 93 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 178 | 93 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 182 | 93 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.21e-05 | 184 | 93 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.21e-05 | 184 | 93 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 4.32e-05 | 185 | 93 | 5 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.43e-05 | 186 | 93 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 4.43e-05 | 186 | 93 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 187 | 93 | 5 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 4.54e-05 | 187 | 93 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.66e-05 | 188 | 93 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.66e-05 | 188 | 93 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.66e-05 | 188 | 93 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 4.66e-05 | 188 | 93 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.78e-05 | 189 | 93 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 189 | 93 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 4.78e-05 | 189 | 93 | 5 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.90e-05 | 190 | 93 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 93 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 93 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.02e-05 | 191 | 93 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 5.15e-05 | 192 | 93 | 5 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.28e-05 | 193 | 93 | 5 | d338a7c0585b69947c37f44aa0381619493e31ea | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.41e-05 | 194 | 93 | 5 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 194 | 93 | 5 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 194 | 93 | 5 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.54e-05 | 195 | 93 | 5 | 3826bfafe85f8aa9a508202ceb2b02e81b090498 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.68e-05 | 196 | 93 | 5 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.68e-05 | 196 | 93 | 5 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.68e-05 | 196 | 93 | 5 | 0e8d649b50be2d707510b897bb97767b5847dff9 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.68e-05 | 196 | 93 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 197 | 93 | 5 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 197 | 93 | 5 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 5.96e-05 | 198 | 93 | 5 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 5.96e-05 | 198 | 93 | 5 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 6.10e-05 | 199 | 93 | 5 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.25e-05 | 200 | 93 | 5 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 7.52e-05 | 208 | 93 | 5 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.41e-04 | 126 | 93 | 4 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 150 | 93 | 4 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.97e-04 | 153 | 93 | 4 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.12e-04 | 155 | 93 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 3.19e-04 | 156 | 93 | 4 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.27e-04 | 157 | 93 | 4 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 158 | 93 | 4 | debebc8534a80e5500051f6fd352dc201585968d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 159 | 93 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.43e-04 | 159 | 93 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 159 | 93 | 4 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 159 | 93 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 160 | 93 | 4 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 160 | 93 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 160 | 93 | 4 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 160 | 93 | 4 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 161 | 93 | 4 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.77e-04 | 163 | 93 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 165 | 93 | 4 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 165 | 93 | 4 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.95e-04 | 165 | 93 | 4 | 479962ce1c3d6636ae62b6709635299748653801 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-04 | 166 | 93 | 4 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.04e-04 | 166 | 93 | 4 | 6210a136efb99d70c2026b6454363f1bd2723558 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-04 | 166 | 93 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.04e-04 | 166 | 93 | 4 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-04 | 166 | 93 | 4 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.04e-04 | 166 | 93 | 4 | 217e0549f88819d02156ea64e8547b658b1c7aef | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-04 | 166 | 93 | 4 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-04 | 166 | 93 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-04 | 166 | 93 | 4 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.32e-04 | 169 | 93 | 4 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-04 | 169 | 93 | 4 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-04 | 169 | 93 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-04 | 169 | 93 | 4 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-04 | 169 | 93 | 4 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-04 | 169 | 93 | 4 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 170 | 93 | 4 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 170 | 93 | 4 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 170 | 93 | 4 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 170 | 93 | 4 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.52e-04 | 171 | 93 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-04 | 171 | 93 | 4 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-04 | 171 | 93 | 4 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 9.04e-09 | 7 | 93 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 9.04e-09 | 7 | 93 | 4 | CID003081001 | |
| Drug | PCB 95 | 5.38e-08 | 10 | 93 | 4 | CID000038012 | |
| Drug | cis-diammineplatinum(II | 6.60e-08 | 3 | 93 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.60e-08 | 3 | 93 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 6.60e-08 | 3 | 93 | 3 | CID000127713 | |
| Drug | aminodantrolene | 6.60e-08 | 3 | 93 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.60e-08 | 3 | 93 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.60e-08 | 3 | 93 | 3 | CID005748312 | |
| Drug | R 478 | 8.42e-08 | 11 | 93 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 8.42e-08 | 11 | 93 | 4 | CID003081323 | |
| Drug | PCB74 | 2.63e-07 | 4 | 93 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 2.63e-07 | 4 | 93 | 3 | CID006444275 | |
| Drug | SC 38249 | 2.63e-07 | 4 | 93 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 2.63e-07 | 4 | 93 | 3 | CID000035682 | |
| Drug | Gvapspat amide | 3.44e-07 | 15 | 93 | 4 | CID000125015 | |
| Drug | mag-fura-2 | 4.01e-07 | 37 | 93 | 5 | CID000123839 | |
| Drug | 4-chloro-m-cresol | 4.01e-07 | 37 | 93 | 5 | CID000001732 | |
| Drug | Fura-2AM | 8.63e-07 | 79 | 93 | 6 | CID000105091 | |
| Drug | NSC759576 | 1.17e-06 | 191 | 93 | 8 | CID000003075 | |
| Drug | chloro-m-cresol | 1.31e-06 | 6 | 93 | 3 | CID000012008 | |
| Drug | MBED | 1.31e-06 | 6 | 93 | 3 | CID000129958 | |
| Drug | AC1O528X | 1.31e-06 | 6 | 93 | 3 | CID006475857 | |
| Drug | NSC114784 | 1.31e-06 | 6 | 93 | 3 | CID000419425 | |
| Drug | AC1OAGFB | ROCK2 SPTBN4 SPTAN1 SPTB NFKB1 PIP5K1B PRKCH EPB41L2 ARF1 ARF3 ITPR1 SOS1 | 2.00e-06 | 539 | 93 | 12 | CID006857345 |
| Drug | Azumoleno | 2.28e-06 | 7 | 93 | 3 | CID000056259 | |
| Drug | borate | 3.07e-06 | 98 | 93 | 6 | CID000007628 | |
| Drug | T0702 | 3.09e-06 | 25 | 93 | 4 | CID000005908 | |
| Drug | aescine | 4.67e-06 | 60 | 93 | 5 | CID004555259 | |
| Drug | fura 2 | 6.94e-06 | 65 | 93 | 5 | CID000057054 | |
| Drug | Caffeine | STIM1 IL12B NFKB1 ANGPTL4 TDO2 TNKS2 RYR1 RYR2 ARF1 RYR3 ITPR1 | 8.16e-06 | 515 | 93 | 11 | ctd:D002110 |
| Drug | strontium | 8.68e-06 | 68 | 93 | 5 | CID000104798 | |
| Drug | AC1L2AC7 | 9.33e-06 | 69 | 93 | 5 | CID000068733 | |
| Drug | CNS 1145 | 9.75e-06 | 33 | 93 | 4 | CID000190902 | |
| Drug | IHC-64 | 9.75e-06 | 33 | 93 | 4 | CID000162753 | |
| Drug | PCB 66 | 1.06e-05 | 11 | 93 | 3 | CID000036185 | |
| Drug | CAS 298-57-7 | 1.23e-05 | 73 | 93 | 5 | CID000002761 | |
| Drug | 2-aminoethyl diphenylborinate | 1.37e-05 | 127 | 93 | 6 | CID000001598 | |
| Drug | Ryanodine | 1.41e-05 | 12 | 93 | 3 | ctd:D012433 | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.49e-05 | 194 | 93 | 7 | 2621_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 1.60e-05 | 196 | 93 | 7 | 2044_DN | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 1.60e-05 | 196 | 93 | 7 | 1821_UP | |
| Drug | maleimide | 1.64e-05 | 131 | 93 | 6 | CID000010935 | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.65e-05 | 197 | 93 | 7 | 3635_DN | |
| Drug | thiophenone | 1.65e-05 | 2 | 93 | 2 | CID009548690 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.65e-05 | 2 | 93 | 2 | ctd:C005147 | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; HL60; HG-U133A | 1.70e-05 | 198 | 93 | 7 | 1376_UP | |
| Drug | AC1L98DX | 1.73e-05 | 38 | 93 | 4 | CID000439957 | |
| Drug | ADPribulose | 1.83e-05 | 13 | 93 | 3 | CID000197570 | |
| Drug | NSC299933 | 1.83e-05 | 13 | 93 | 3 | CID000431902 | |
| Drug | NAADP | 1.92e-05 | 39 | 93 | 4 | CID000123952 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | STIM1 SPTB PLCL2 EIF4G2 APOL3 PRKCH RYR1 RYR2 RYR3 ITPR1 SOS1 | 2.03e-05 | 568 | 93 | 11 | CID000000806 |
| Drug | dipyrone | 2.13e-05 | 40 | 93 | 4 | CID000003110 | |
| Drug | phenylhydrazine | 2.17e-05 | 82 | 93 | 5 | CID000007516 | |
| Drug | FPL 64176 | 2.90e-05 | 15 | 93 | 3 | CID000003423 | |
| Drug | escina | 3.12e-05 | 44 | 93 | 4 | CID006433489 | |
| Drug | lindane | 4.08e-05 | 154 | 93 | 6 | CID000000727 | |
| Drug | kazinol B | 4.30e-05 | 17 | 93 | 3 | CID000480869 | |
| Drug | ts M | 4.42e-05 | 48 | 93 | 4 | CID000428025 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 4.94e-05 | 3 | 93 | 2 | CID000080262 | |
| Drug | flubendiamide | 4.94e-05 | 3 | 93 | 2 | CID011193251 | |
| Drug | lysosphingomyelin | 5.05e-05 | 160 | 93 | 6 | CID000005263 | |
| Drug | methylcoumarin | 5.15e-05 | 18 | 93 | 3 | CID000007092 | |
| Drug | indo-1 | 5.39e-05 | 99 | 93 | 5 | CID000105060 | |
| Drug | AC1MW7VF | 6.10e-05 | 19 | 93 | 3 | CID000414699 | |
| Drug | AC1L380G | 6.10e-05 | 19 | 93 | 3 | CID000084698 | |
| Drug | loperamide | 7.14e-05 | 105 | 93 | 5 | CID000003954 | |
| Drug | phosphine oxide | 7.81e-05 | 107 | 93 | 5 | CID000166931 | |
| Drug | NSC226080 | ROCK2 DOCK5 IL12B NFKB1 EIF4G2 PSMD1 PRKCH TSC1 RYR1 RYR2 RYR3 ITPR1 | 8.06e-05 | 782 | 93 | 12 | CID000005040 |
| Drug | Cinildipine | 8.14e-05 | 56 | 93 | 4 | CID000002752 | |
| Drug | indo-1/AM | 8.32e-05 | 21 | 93 | 3 | CID000123918 | |
| Drug | AC1L1CR9 | 8.32e-05 | 21 | 93 | 3 | CID000002023 | |
| Drug | A-30 | 9.85e-05 | 4 | 93 | 2 | CID003028528 | |
| Drug | Bastadin 10 | 9.85e-05 | 4 | 93 | 2 | CID009589366 | |
| Drug | nilvadipine | 1.07e-04 | 60 | 93 | 4 | CID000004494 | |
| Drug | IAA-94 | 1.14e-04 | 61 | 93 | 4 | CID000003667 | |
| Drug | apocynin | 1.16e-04 | 186 | 93 | 6 | CID000002214 | |
| Drug | AC1NBU2S | 1.19e-04 | 117 | 93 | 5 | CID004473765 | |
| Drug | lercanidipine | 1.29e-04 | 63 | 93 | 4 | CID000065866 | |
| Drug | AC1L96VB | 1.34e-04 | 191 | 93 | 6 | CID000439200 | |
| Drug | dimyristoylphosphatidylcholine | 1.37e-04 | 64 | 93 | 4 | CID000026197 | |
| Drug | fluo-3 | 1.45e-04 | 122 | 93 | 5 | CID000104978 | |
| Drug | Clorocruoro Hem | 1.51e-04 | 123 | 93 | 5 | CID003518809 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 1181_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 1.54e-04 | 196 | 93 | 6 | 2005_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 1851_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 4608_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 5302_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; HL60; HG-U133A | 1.59e-04 | 197 | 93 | 6 | 1789_DN | |
| Drug | 4-ethylguaiacol | 1.64e-04 | 5 | 93 | 2 | CID000062465 | |
| Drug | A 68930 | 1.64e-04 | 5 | 93 | 2 | ctd:C065380 | |
| Drug | gallopamil | 1.64e-04 | 67 | 93 | 4 | CID000001234 | |
| Drug | NSC-695672 | 1.64e-04 | 67 | 93 | 4 | CID000393593 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 6324_DN | |
| Drug | tBuBHQ | 1.84e-04 | 69 | 93 | 4 | CID000002374 | |
| Drug | AC1L1JVU | 2.17e-04 | 72 | 93 | 4 | CID000005229 | |
| Drug | caged InsP3 | 2.23e-04 | 29 | 93 | 3 | CID000122248 | |
| Drug | lanthanum | 2.41e-04 | 136 | 93 | 5 | CID000023926 | |
| Drug | ethosuximide | 2.41e-04 | 74 | 93 | 4 | CID000003291 | |
| Drug | 2,4,6-trichloroanisole | 2.45e-04 | 6 | 93 | 2 | CID000006884 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.31e-08 | 3 | 85 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.31e-08 | 3 | 85 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | midregional pro atrial natriuretic peptide measurement | 8.20e-06 | 2 | 85 | 2 | EFO_0008468 | |
| Disease | mean reticulocyte volume | STIM1 MTHFR ITSN1 SPTB NFKB1 PLCL2 ZBTB40 MAST1 REXO1 EPB41L2 SLC4A1 | 1.85e-05 | 799 | 85 | 11 | EFO_0010701 |
| Disease | Elliptocytosis found | 4.90e-05 | 4 | 85 | 2 | C0427480 | |
| Disease | Hereditary elliptocytosis | 4.90e-05 | 4 | 85 | 2 | cv:C0013902 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 4.90e-05 | 4 | 85 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | hereditary spherocytosis (is_implicated_in) | 8.15e-05 | 5 | 85 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 8.15e-05 | 5 | 85 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 8.15e-05 | 5 | 85 | 2 | C0221409 | |
| Disease | Elliptocytosis, Hereditary | 1.22e-04 | 6 | 85 | 2 | C0013902 | |
| Disease | fasting blood glucose measurement | 1.85e-04 | 287 | 85 | 6 | EFO_0004465 | |
| Disease | Hereditary spherocytosis | 2.27e-04 | 8 | 85 | 2 | C0037889 | |
| Disease | Hematological Disease | 2.27e-04 | 8 | 85 | 2 | C0018939 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.56e-04 | 195 | 85 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | CUL1 TICRR MTHFR ITSN1 SPTB NFKB1 PLCL2 MAST1 UBE3C EPB41L2 SLC4A1 | 3.27e-04 | 1105 | 85 | 11 | EFO_0004528 |
| Disease | urate measurement, bone density | 4.18e-04 | 619 | 85 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.21e-04 | 128 | 85 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.21e-04 | 128 | 85 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.21e-04 | 128 | 85 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.21e-04 | 128 | 85 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.21e-04 | 128 | 85 | 4 | C0007134 | |
| Disease | Anemia, Hemolytic, Acquired | 6.27e-04 | 13 | 85 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 6.27e-04 | 13 | 85 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 6.27e-04 | 13 | 85 | 2 | C0002889 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 6.27e-04 | 13 | 85 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 6.27e-04 | 13 | 85 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 6.27e-04 | 13 | 85 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 6.27e-04 | 13 | 85 | 2 | C4551952 | |
| Disease | Microangiopathic hemolytic anemia | 6.27e-04 | 13 | 85 | 2 | C0221021 | |
| Disease | Congenital Structural Myopathy | 6.27e-04 | 13 | 85 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 7.30e-04 | 14 | 85 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 7.30e-04 | 14 | 85 | 2 | C0410207 | |
| Disease | hemoglobin A1 measurement | 7.65e-04 | 520 | 85 | 7 | EFO_0007629 | |
| Disease | glycerate measurement | 8.40e-04 | 15 | 85 | 2 | EFO_0021029 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 8.40e-04 | 15 | 85 | 2 | C3645536 | |
| Disease | anemia (implicated_via_orthology) | 8.40e-04 | 15 | 85 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.98e-04 | 148 | 85 | 4 | C0279702 | |
| Disease | diacylglycerol 44:7 measurement | 9.59e-04 | 16 | 85 | 2 | EFO_0020069 | |
| Disease | Congenital Fiber Type Disproportion | 1.22e-03 | 18 | 85 | 2 | C0546264 | |
| Disease | susceptibility to scarlet fever measurement | 1.56e-03 | 79 | 85 | 3 | EFO_0008409 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.62e-03 | 80 | 85 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | DOCK5 MTHFR ITSN1 SPTB ANGPTL4 PLCL2 APOL3 ZBTB40 MAST1 REXO1 SLC4A1 | 1.66e-03 | 1347 | 85 | 11 | EFO_0005192 |
| Disease | uric acid measurement | 1.91e-03 | 610 | 85 | 7 | EFO_0004761 | |
| Disease | West Syndrome | 2.17e-03 | 24 | 85 | 2 | C0037769 | |
| Disease | calcium measurement | 2.25e-03 | 628 | 85 | 7 | EFO_0004838 | |
| Disease | creatinine measurement | 2.26e-03 | 995 | 85 | 9 | EFO_0004518 | |
| Disease | cognitive function measurement | AKAP6 TULP4 PPFIA2 PLCL2 CYP26C1 MAST1 THSD7B ARMH3 RYR3 SOS1 CEMIP | 2.70e-03 | 1434 | 85 | 11 | EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLLSHGAHIEALDKD | 151 | Q5TYW2 | |
| LLLKHSHPNDDKDSG | 421 | P48751 | |
| LLALKGHDALGHQEE | 1321 | Q5SNV9 | |
| LLDHKHLDHEVAKPA | 146 | Q9BY76 | |
| KLLSHGAHIEALDKD | 151 | Q5CZ79 | |
| ALLLKHSHAGELEAL | 156 | P02730 | |
| KLLSHGAHIEALDKD | 151 | Q4UJ75 | |
| AAEITDKLGLHSLRH | 136 | P61204 | |
| DTKDEHRLHSGKLCL | 381 | Q5T2E6 | |
| AADKHGKTALLHALA | 166 | Q9NWX5 | |
| HISEGGKLVIKDHDE | 76 | Q8WUJ3 | |
| HELHELGLLKDHSLE | 276 | Q16769 | |
| GKAVFLARDKHHLSD | 161 | Q8IXN7 | |
| SLHLITIKAHDADLG | 476 | Q9NPG4 | |
| ELHKLKVQLDGHERS | 236 | Q96SN7 | |
| KLLSHGAHIEALDKD | 151 | Q5SQ80 | |
| RHKKLHLGLDVEASE | 146 | Q96LL4 | |
| HPEAGSFEADLKHLK | 201 | P42898 | |
| HREGKFKDTLHLIGE | 61 | P43627 | |
| EHHEKAVELLKAAKD | 166 | O14910 | |
| EHHEKAVELLKAAQG | 151 | Q9NUP9 | |
| FAGLLKLKELHLEHN | 201 | Q86VH4 | |
| KSDLLHTKSLRGHKD | 46 | Q9NYK6 | |
| AVLLNKLHHAADLEK | 86 | Q14643 | |
| HREGKFKDTLHLIGE | 61 | P43628 | |
| LKALKSLFEHHKALD | 151 | O75335 | |
| KTLHRNLELEHKELG | 1196 | Q9P219 | |
| LEEKVAELHKTHRGL | 371 | O43491 | |
| VDLHHAKDSEGVDIK | 406 | O43491 | |
| LGIHFLDHSLKEKEE | 271 | O14986 | |
| EILGIKDLHADHAAS | 191 | Q330K2 | |
| GALKELHEVGLHDNL | 141 | Q8N456 | |
| LKALKSLFEHHKALD | 161 | Q13136 | |
| VLSHSLLLLHKKEDG | 96 | P29460 | |
| ELGKLDLIHESILHK | 216 | P78344 | |
| AEGHAKEGHLVKTDI | 306 | Q9Y2H9 | |
| DLLSDTHLHLGKELE | 1026 | Q9UG01 | |
| EGVKHHLTLLLKLED | 456 | Q9UHY1 | |
| LHLHKLDELDCLVKG | 131 | Q9H999 | |
| KLLSHGAHIEALDKD | 151 | Q5VUR7 | |
| SVHDEEGKLLEKAIH | 471 | Q9H7D0 | |
| DGLGELKKLLETHIH | 331 | Q13616 | |
| PDHSHLKHALEKAEE | 1401 | Q15811 | |
| HLTEASGKLHLLDKL | 341 | Q86WJ1 | |
| KHLHEGAKSASAEEL | 361 | O95236 | |
| AAEITDKLGLHSLRH | 136 | P84077 | |
| HLEGAISEKLHEDKA | 246 | Q6V0L0 | |
| IGHAVAHLKKADEAN | 316 | P09913 | |
| ISLLDKHGRNHKVLD | 586 | P21817 | |
| EGHIKSIISLLDKHG | 591 | Q92736 | |
| DDKGRTHELEHSAIK | 106 | Q93100 | |
| ALKSLFEHHKALDEK | 176 | O75334 | |
| LHETGIFKKHLLLDA | 376 | Q8N323 | |
| IHKLHKFLGSDEEDK | 421 | Q99567 | |
| NEFGHHKIDVLKADL | 256 | Q5JXM2 | |
| GHSLESDLLALKVIH | 1141 | Q8N1G1 | |
| AKGFLAEEKHLHVLI | 111 | Q8TC12 | |
| HLHLETFKAVLDGLD | 91 | P78395 | |
| HEAEEKLSEHKALVS | 5136 | Q8NF91 | |
| HNENLLLEGKAHTKD | 6146 | Q8NF91 | |
| SLFDEKRHEHLLSKG | 266 | P48775 | |
| HEHLHSIGTKEGLKE | 1036 | Q9UPR0 | |
| SHADHLLALLESPKA | 121 | Q6P5W5 | |
| ASLGVIHKGHEKEAL | 406 | Q99460 | |
| LKHKLDHVIGELEDT | 151 | Q8TBB0 | |
| DIHELSVKLLGHIED | 251 | Q07889 | |
| KALLALNHGLDKAHS | 581 | Q13586 | |
| EIKEVAAAAHLEKGH | 186 | Q9NWQ8 | |
| HESLSHELKAAEKDG | 221 | Q8IZV5 | |
| EEGHQLLELIASHKA | 841 | Q13023 | |
| GDRDHEHLQKSAKAL | 791 | Q9NRJ4 | |
| ELESHLAKKDHLLLE | 911 | Q92574 | |
| LLSEAEHHGIGDLKS | 1466 | Q7Z2Z1 | |
| LESEGKDHGLELSIH | 1716 | Q7Z2Z1 | |
| SILKDILHLAEHDGT | 91 | O43361 | |
| KHEPIAHLLDGQDKA | 1406 | Q9BX84 | |
| SLLDKHGRNHKVLDI | 586 | Q15413 | |
| KELDSLHGEKVHLKE | 86 | Q8N0S2 | |
| LQKKHALLEADVAAH | 716 | Q13813 | |
| LLDKHGHLKLADFGT | 221 | O75116 | |
| HLVEADDLLQKHGLL | 566 | Q9H254 | |
| HETLDHLIKGRLKEN | 471 | Q9NRW7 | |
| EIKAHLLSAEFGKHL | 546 | P11277 | |
| FGKHLLEVEDLLQKH | 556 | P11277 | |
| ALGKELEHLSHIKES | 141 | Q6I9Y2 | |
| DVHAKDKGDLVPLHN | 236 | Q9H2K2 | |
| LHKETHLGKVSLEGE | 146 | Q7Z398 | |
| HDTFDLHGKILKSNL | 126 | Q6PF04 | |
| CSLLLHAREHKDKGL | 576 | Q8N1G0 | |
| LLLSHAAHLEGKKDN | 26 | Q9C0I4 | |
| SALNKHGEIHAREKL | 831 | Q8IWY8 | |
| SLLKDILHLAEHDGT | 91 | P17021 | |
| DSKKELDKHQLEAHG | 776 | Q9NUA8 | |
| KLLGTSADVDIHHLA | 846 | Q15386 | |
| KLDNVLLDHEGHCKL | 481 | P24723 | |
| KHANEKEDIHSLALL | 456 | Q9C099 | |
| DHIKGLETHLIALKL | 906 | Q14CX7 | |
| NSVLHLAAKEGHDKV | 616 | P19838 |